Raison, Charles L, Lin, Jin-Mann S, Reeves, William C · Brain, behavior, and immunity · 2009 · DOI
Researchers measured inflammation markers in the blood of people with ME/CFS, people with fatigue that didn't quite meet ME/CFS criteria, and healthy controls. They found that inflammation markers were elevated in both fatigue groups compared to healthy people. However, when they accounted for factors like depression, weight, age, and medications, the connection to ME/CFS specifically became less clear, suggesting that general fatigue and unwellness—not ME/CFS alone—may be linked to immune activation.
This study addresses a key question about whether ME/CFS involves specific immune dysregulation by using a large, population-based sample with appropriate controls and adjustment for confounders—methodological improvements over prior work. Understanding whether immune activation is specific to ME/CFS or a general feature of fatigue and unwellness helps researchers refine disease mechanisms and may guide treatment development.
This study does not establish causality; cross-sectional design cannot determine whether inflammation causes fatigue or results from it. The loss of statistical significance for CFS after adjustment suggests that immune activation may be more closely related to functional impairment and depression than to ME/CFS diagnosis specifically, raising questions about whether inflammation is a primary ME/CFS biomarker. The study also does not clarify which specific immune abnormalities drive ME/CFS symptoms.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →